GlassScriptPhysician profile
Nishi Patel
NPI 1821435876
$41,001.65
in general payments reported to CMS, 2019-2025
25 companies · $32K in 2025
The $32K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,452 · 2020: $856 · 2021: $1,370 · 2022: $804 · 2023: $1,700 · 2024: $1,366 · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $4,553 · Food and Beverage: $4,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,931.25 |
| Travel and Lodging | $4,553.47 |
| Food and Beverage | $4,035.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $31,658.08 | 2024-2025 | Wegovy |
| Abbott Laboratories | $4,539.70 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Heartmate Touch |
| Novo Nordisk As | $2,008.62 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $536.00 | 2020-2023 | Farxiga |
| Abiomed | $401.82 | 2021-2025 | Impella |
| Heartflow, INC. | $325.81 | 2024-2025 | |
| Edwards Lifesciences Corporation | $266.64 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $248.95 | 2020-2024 | |
| Pfizer INC. | $200.17 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $129.51 | 2023 | Gore Cardioform Septal Occluder |
| Boston Scientific Corporation | $122.00 | 2019 | |
| Merck Sharp & Dohme LLC | $104.22 | 2021-2024 | Verquvo |
| Getinge USA Sales, LLC | $98.20 | 2023 | Cardiohelp |
| Impulse Dynamics (USA) INC. | $75.57 | 2023-2024 | Optimizer, Optimizer |
| Actelion Pharmaceuticals US, INC. | $63.65 | 2023 | Opsumit, Uptravi |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $48.30 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.38 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.40 | 2024-2025 | Lifevest |
| Sun Pharmaceutical Industries INC. | $24.36 | 2023 | |
| American Regent | $23.61 | 2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $18.72 | 2025 | |
| Terumo Medical Corporation | $16.72 | 2019 | |
| Amgen INC. | $12.92 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.50 | 2019 | |
| Cook Medical LLC | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishi Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.